Tevogen.AI, Microsoft & Databricks Build Beta PredicTcell Model
Tevogen.AI to explore external market opportunities as a potential revenue source. Beta version to incorporate oncology targets, enhancing the accuracy and diversity of the PredicTcell model and potentially accelerating cancer immunotherapy development. Tevogen.AI to develop enhanced analytics and visualization tools, for the PredicTcell model to support its internal R&D teams. Tevogen (“Tevogen Bio Holdings Inc.” or…
